CoChat

Obesity and Weight Gain Are Associated With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Kim, Yejin, Chang, Yoosoo, Cho, Yong Kyun, Ahn, Jiin, Shin, Hocheol, Ryu, Seungho · 2019 · Clinical Gastroenterology and Hepatology
Cited by 79

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Background & Aims The effects of weight change on the progression of liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) in the general population are unclear. We evaluated the association of weight change and baseline body mass index (BMI) with fibrosis progression, determined by non‐invasive measurement of a marker, in young and middle‐aged adults with NAFLD. Methods We performed a prospective cohort study of 40,700 adults with NAFLD in Korea who received regular health screening examinations and were followed for a median 6.0 years. Weight change was defined as the difference between weights measured at baseline and at a subsequent follow‐up visit. The progression from a low to an intermediate or high probability of advanced fibrosis was assessed using the aspartate aminotransferase to platelet ratio index (APRI). Results During 275,421.5 person‐years of follow‐up, 5454 subjects with a low APRI progressed to an intermediate or high APRI. Multivariable‐adjusted hazard ratios for APRI progression, determined by comparing the first and second weight change quintiles (the weight‐loss group) and the fourth and fifth quintiles (weight‐gain group) with the third quintile (weight‐stable group, reference), were 0.68 (95% CI, 0.62–0.74), 0.86 (95% CI, 0.78–0.94), 1.17 (95% CI, 1.07–1.28), and 1.71 (95% CI, 1.58–1.85), respectively. The multivariable‐adjusted hazard ratios for APRI progression were determined by comparing subjects with BMIs of 23–24.9, 25–29.9, and ≥30 with subjects with BMIs of 18.5–22.9 kg/m2 (reference); these ratios were 1.13 (95% CI, 1.02–1.26), 1.41 (95% CI, 1.28–1.55), and 2.09 (95% CI, 1.86–2.36), respectively. Conclusions In a prospective cohort study of 40,700 adults with NAFLD, we found obesity and weight gain to be independently associated with increased risk of fibrosis progression, based on APRI. Maintaining a normal healthy weight and preventing weight gain may help reduce fibrosis progression in individuals with NAFLD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2018.07.006

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 79

Metadata

Authors
Kim, Y., Chang, Y., Cho, Y. K., Ahn, J., Shin, H., & Ryu, S.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2019-02
Volume
17
Issue
3
Pages
543-550.e2
ISSN
1542-3565 (ISSN-L)
OpenAlex
W2884734727
Cited by
79
References
10
FWCI
5.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.